Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Abdellatif, Awad | Al-tonsy, Ahmad H. | Awad, Mahmoud E. | Roberfroid, M. | Khan, M. Nezam Ullah
Affiliations: Garyounis Faculty of Medicine, Pharmacology Department, Benghazi, Lybia | Benha Faculty of Medicine, Medical Biochemistry Department, Egypt | Mansoura Faculty of Medicine, Forensic Medicine and Clinical Toxicology Department, Egypt | Ecole de Pharmacie, Bruxelles, Belgium | Garyounis Faculty of Medicine, Pathology Department, Benghazi, Lybia
Note: [] Address for correspondence: Ahmad Hisham Al-tonsy, 10 Metwaly Noor Str., From Tayaran Str., Beside Dr. Abou El-azayem Hospital, Nasr City, Cairo, Egypt. Tel.: +2 02 4026748 or +2 0105251867; E-mail: Altonsi2000@yahoo.com
Abstract: Although peroxisome proliferators are considered non-genotoxic agents, most of them, nevertheless, were found to promote and/or induce, hepatocellular carcinoma (HCC) in rodents. The aim of the present study is, first, to investigate whether the peroxisome proliferator perfluorooctanoic acid (PFOA) possesses inherent liver cancer promoting activity, and second, to study the possible mechanisms involved. To acheive these aims two protocols have been applied, a biphasic protocol (initiation by diethyl-nitrozamine (DEN) 200 mg/kg i.p. followed by treatment with 0.005% or 0.02% perflourooctanoic acid (PFOA) for 14 and 25 weeks) and a triphasic initiation, selection-promotion (IS) protocol (initiation by giving 200 mg/kg DEN i.p. followed by a selection procedure for 2 weeks consisting of giving 0.03% 2-acetylaminofluorene (2-AAF) in diet). In the middle of this treatment a single oral dose of carbon tetrachloride (2.0 ml/kg) was given, followed by giving diet containg 0.015% of PFOA for 25 weeks. After applying both protocols, our results showed slight increase in the catalase activity while acyl CoA oxidase activity was markedly increased. Both experiments indicated that PFOA has a liver cancer promoting activity. Other groups of rats were given either basal diet or diet containing 0.02% PFOA. Five or nine weeks later they were sacrificed and the levels of 8-hydroxydeoxyguanosine in the isolated DNA were estimated. The data showed a slight nonetheless insignificant increase in 8-hydroxydeoxyguanosine. From the present data, it is concluded that PFOA is a true liver cancer promoter that may not require extensive initial DNA damage for its promoting activity.
Keywords: perfluorooctanoic acid (PFOA), diethylnitrosamine, (DEN), hepatocellular carcinoma (HCC), 2-acetylaminofluorene (2-AAF)
Journal: Disease Markers, vol. 19, no. 1, pp. 19-25, 2004
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl